KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Debt Ratio (2016 - 2026)

West Pharmaceutical Services has reported Debt Ratio over the past 18 years, most recently at 0.05 for Q1 2026.

  • Quarterly Debt Ratio fell 11.87% to 0.05 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.05 through Mar 2026, down 11.87% year-over-year, with the annual reading at 0.05 for FY2025, 14.59% down from the prior year.
  • Debt Ratio was 0.05 for Q1 2026 at West Pharmaceutical Services, up from 0.05 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.06 in Q1 2022 and troughed at 0.02 in Q4 2023.
  • The 5-year median for Debt Ratio is 0.06 (2024), against an average of 0.05.
  • Biggest five-year swings in Debt Ratio: tumbled 66.74% in 2023 and later surged 192.51% in 2024.
  • Tracing WST's Debt Ratio over 5 years: stood at 0.06 in 2022, then crashed by 66.74% to 0.02 in 2023, then skyrocketed by 192.51% to 0.06 in 2024, then fell by 14.59% to 0.05 in 2025, then increased by 3.9% to 0.05 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.05, 0.05, and 0.05 for Q1 2026, Q4 2025, and Q3 2025 respectively.